Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000009

CFO AND TREASURER sold 21,000 shares at an average $478.60 ($10,050,597)

  • CFO AND TREASURER acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Exercise or conversion : show line 1 in the form 10b5-1 +21,000 $146.03 $3,066,630 29,142 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −400 $475.08 $190,034 28,742 D
2025-12-08 Sale : show line 3 in the form 10b5-1 −2,957 $476.17 $1,408,046 25,785 D
2025-12-08 Sale : show line 4 in the form 10b5-1 −6,529 $477.18 $3,115,502 19,256 D
2025-12-08 Sale : show line 5 in the form 10b5-1 −3,295 $477.97 $1,574,907 15,961 D
2025-12-08 Sale : show line 6 in the form 10b5-1 −3,139 $479.16 $1,504,074 12,822 D
2025-12-08 Sale : show line 7 in the form 10b5-1 −1,559 $480.03 $748,369 11,263 D
2025-12-08 Sale : show line 8 in the form 10b5-1 −477 $481.22 $229,544 10,786 D
Open-market sales · 21,000 sh · avg $478.60 · $10,050,597

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-12-08 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option −21,000 $146.03 2027-03-15 21,000 3,517 D
Loading xslF345X05/primarydocument.xml…